secwatch.observer — SEC 8-K summary
======================================

Issuer:     DMK PHARMACEUTICALS Corp (—)
CIK:        0000887247
Form:       8-K
Filed at:   2023-10-17T23:59:59+00:00
Accession:  0001387131-23-012324
Event type: regulatory
Sentiment:  negative
Materiality: 0.85
Item codes: 3.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

DMK Pharmaceuticals receives Nasdaq delisting notice for failing to meet $35M market value requirement
--------------------------------------------------------------------------------

- On Oct 11, 2023, DMK received Nasdaq delisting notice for failing to maintain minimum $35M market value for 30 consecutive trading days.
- Company plans to timely request a hearing before Nasdaq Hearings Panel to stay delisting.
- Previously, on Apr 12, 2023, DMK was given 180 days to regain compliance, which expired Oct 9, 2023.
- No assurance that panel will grant continued listing or that DMK will regain compliance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/887247/000138713123012324/0001387131-23-012324-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/887247/000138713123012324/dmk-8k_101123.htm
  HTML page:      https://secwatch.observer/filing/0001387131-23-012324

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer